| Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source | New England Journal of Medicine | 2018 | 432 |
| Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study | Thrombosis and Haemostasis | 2018 | 114 |
| The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the Anesthetic Management of Pregnant and Postpartum Women Receiving Thromboprophylaxis or Higher Dose Anticoagulants | Anesthesia and Analgesia | 2018 | 107 |
| Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study | Thrombosis and Haemostasis | 2018 | 98 |
| Reversal agents for non-vitamin K antagonist oral anticoagulants | Nature Reviews Cardiology | 2018 | 92 |
| Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery | Journal of the American Society of Nephrology: JASN | 2018 | 69 |
| Do sulphonylureas still have a place in clinical practice? | Lancet Diabetes and Endocrinology,the | 2018 | 61 |
| Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018 | Canadian Journal of Cardiology | 2018 | 58 |
| Risk of recurrent venous thromboembolism according to baseline risk factor profiles | Blood Advances | 2018 | 46 |
| Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: A retrospective study | Research and Practice in Thrombosis and Haemostasis | 2018 | 42 |
| Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery Disease | Journal of the American College of Cardiology | 2018 | 39 |
| Body temperature and mouse scoring systems as surrogate markers of death in cecal ligation and puncture sepsis | Intensive Care Medicine Experimental | 2018 | 38 |
| Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial | Journal of Stroke and Cerebrovascular Diseases | 2018 | 37 |
| Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers | Journal of Thrombosis and Haemostasis | 2018 | 29 |
| Expert Consensus Guidelines for Stocking of Antidotes in Hospitals That Provide Emergency Care | Annals of Emergency Medicine | 2018 | 28 |
| Low-density lipoprotein (LDL)-dependent uptake of Gram-positive lipoteichoic acid and Gram-negative lipopolysaccharide occurs through LDL receptor | Scientific Reports | 2018 | 24 |
| 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis: Factor XI as a Target for New Anticoagulants | Arteriosclerosis, Thrombosis, and Vascular Biology | 2018 | 23 |
| Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial | Circulation | 2018 | 23 |
| Loss-of-function PCSK9 mutants evade the unfolded protein response sensor GRP78 and fail to induce endoplasmic reticulum stress when retained | Journal of Biological Chemistry | 2018 | 22 |
| Fibrinolysis: strategies to enhance the treatment of acute ischemic stroke | Journal of Thrombosis and Haemostasis | 2018 | 20 |
| Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction) | Circulation: Cardiovascular Quality and Outcomes | 2018 | 20 |
| Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering | Arteriosclerosis, Thrombosis, and Vascular Biology | 2018 | 18 |
| Pediatric superior vena cava syndrome: An evidence-based systematic review of the literature | Pediatric Blood and Cancer | 2018 | 17 |
| Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective study | Journal of Thrombosis and Thrombolysis | 2018 | 16 |
| High-density lipoprotein protects cardiomyocytes against necrosis induced by oxygen and glucose deprivation through SR-B1, PI3K, and AKT1 and 2 | Biochemical Journal | 2018 | 16 |
